Recent Updates on Morpholino Pyrimidine Derivatives as Promising PI3K/Akt/mTOR Inhibitors
Crossref DOI link: https://doi.org/10.1007/s42250-024-01163-2
Published Online: 2024-12-26
Published Print: 2025-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Keertika, Khandelwal
Behera, Swagatika
Sharma, Nutan https://orcid.org/0000-0003-4728-5528
Text and Data Mining valid from 2024-12-26
Version of Record valid from 2024-12-26
Article History
Received: 12 August 2024
Accepted: 24 November 2024
First Online: 26 December 2024
Declarations
:
: The Authors declare no conflict of interest.
: Not applicable.